Updates in PAH management: Insights from the 6th WSPH
The faculty will discuss multi-parameter risk assessment as recommended by the WSPH proceedings, how relevant risk assessment is for themselves, and what role escalating to double or triple combination therapy plays in their clinical practice.
- To reflect upon the relevance of risk stratification in PAH, and the implication on daily clinical practice
- To integrate new data on combination therapy into clinical scenarios
- Professor Sean Gaine
- Professor Nazzareno Galiè